Mary E. Dixon

Mary is our CEO and founder. With over 25 years’ experience in the clinical research industry, Mary has contributed to the development of 14 compounds and has led biomarker identification and development teams and facilitated cross-functional, cross-divisional collaborations to develop medical devices, including decision support software that serve patients with rare diseases. Mary has spent her career identifying patients’ unmet needs and driving the creation of solutions that go “beyond therapeutics,” to address those needs. Mary founded Cogent Pharma and it’s subsidiary, Innovenn, which lead to the team’s understanding of the need to apply human factors to the development process for medical devices, medical device software (SaMD), and combination products. In 2019, Mary founded Improvita and leads the team towards the goal of developing safe and effective medical devices.